In tro d u ctio n T he luteinizing horm one releasing ho rm o n e (L H R H ) is functional in the endocrinology of re p ro duction. A ntagonists of L H R H have been w idely view ed as potential antiovulatory substances tow ard goals of control of conception and population. In this in tern atio n al field of research, over a th o u san d analogs of L H R H have been synthesized and biologi cally evaluated. P rotection of the C -term inal of an antagonist against enzym atic degradation has been an im p o rtan t aspect in peptide design and has been studied tow ard such p ro tection (background re fe r ences; F olkers et al. [1] ).
W e now describe the synthesis and the results of antiovulatory tests in rats of 24 new analogs of L H R H . Ten of these analogs have an A zagly m oiety, I, on the C -term inal. Two analogs have an acetylhydrazide m oiety, II, in position 10 .
I, -N H -N H -C O -N H 2; II, -N H -N H -C O -C H 3; III, -N H -C H 2-C O -N H 2.
Abbreviations: [2] and by F olkers et al. [3] .
E x p erim en tal

Materials.
A m in o acid derivatives w ere purchased from P en in su la L ab o rato rie s, San C arlos, C A . The a-a m in o functions w ere p ro tected by the BO Cg ro u p , ex cep t for arginine which had the A O Cgroup. Side-chain functions w ere p ro tected by the benzyl group for serine and th reo n in e, tosyl group for arginine and h istidine, and o-brom ocarbobenzoxy or 2 ,6 -dichlorobenzyl group for tyrosine. B O C -/?-chloro-D -phenylalanine and 3,4-dehydro-L -proline w ere pro v id ed by the S outhw est F o u n d atio n for R esearch an d E d u ca tio n , San A n to n io , TX. p- F o r th e peptides on the B H A -resin, the acetylatio n o f the N -term inus was accom plished by adding 25% acetic anhydride in dichlorom ethane in p re sence of pyridine. T he reactions tim e was 20 m i n u tes. T he com pleted peptides w ere rem oved from th e B H A resins by trea tm e n t w ith anhydrous liquid H F containing ca. 10% anisole for 1 h at 0 °C, as d escrib ed [5] , F o r th e peptides on the chlorom ethyl resin (d e signed fo r p rep aratio n of A zagly10 peptides) the fol low ing p rocedure was used. T ry p to p h an and u n n atu ral am ino acids w ere e stab lished, b ut w ere not q uantitated. T he results are in T ab le V. O ptical rotations w ere m easured in a Perkin-E lm e r 141 digital rea d o u t polarim eter.
[N -A c -D -T h r '.p F -D -P he2, D -T r p 36, A zaglyI0]-LH RH 6
0(4/4)
[N -A c -N orval1, p F -D -P he2, D -T r p 3 6, A zagly10]-LH R H 3 0(5/5)
[N -A c -A la 1, p F -D -Phe2. D -T r p 3 6, N H N H C O C H ,10]-L H R H 6
0(3/3) 23 [N -A c -A la 1, p F -D -Phe2, D -2-N al3 6]-LH R H 6
0(5/5) 24 [N -A c -A la 1, p F -D -Phe2, D -2-N al3 6, A zagly10]-LH RH
Biological assays. T he peptides w ere assayed for activity to inhibit ovulation in rats, as described [8] . R esu lts of the bioassays are in T ables I, II and III).
R esu lts and D iscussion
O u r previous synthesis (Folkers et al. [1] ) on A zagly10-analogs of L H R H and the data from antiovula to ry assays show ed th a t an A zagly10-m oiety m ay not d ep ress activity, and m ay even allow equal or higher activity than the corresponding analogs w ith the G ly 10-m oiety. The relative activity of A zagly10 and G ly u)-analogs d ep ended upon the analog, and indi cated th a t the principle of protection of the C -term inal position by A zagly or a similar su b stitu en t is a t tractiv e. Such p ro tection m ight be expressed by a hig h er potency or a prolonged antiovulatory activity.
T ables I, II and III contain the groupings of A zag ly10 an d related analogs.
T h e A zagly10-analogs w ere p rep a re d from the ch lo ro m eth y l M errifield resin by attaching the p en u l tim ate am ino acid (P ro ) to the resin, and com pleting o f th e synthesis to th e N -term inus. T he A zagly10-m oiety was th en in tro d u c ed after th e n o n ap ep tid e was cleaved from th e resin.
In o u r prev io u s study [1] , the p ro tected and Nacety lated n o n ap e p tid e resins w ere su b jected to hydrazinolysis to affo rd p ro tec ted p ep tid es as hydrazides w hich w ere th en co u p led w ith sem icarbazide via the azide m eth o d . T he side-chain p ro tec ted groups w ere th e n rem o v ed w ith liquid H F . T he conditions of hydrazinolysis resu lted in a p artial rem oval of th e Nterm in al acetyl g ro u p , w hich caused serious difficul ties in th e p u rification of A zagly10-analogs. T h e re fo re, we m odified th e p ro ced u re for the p rep aratio n of A zagly 10-analogs.
T h e new p ro ce d u re consisted of (1) hydrazinolysis o f N -a-r-B o c-n o n ap ep tid e resin (side-chain p ro te c te d ); (2) reactio n of the resulting N -a-f-Bocn o n ap e p tid e w ith sodium cyanate u n d er acidic condi tions [1, 6] to co n v ert th e hydrazide to the azaglycine am id e; (3) ro u tin e rem oval of f-Boc by T F A , fol low ed by acety latio n w ith 25% acetic anhydride in pyridine; (4) d eprotection of the pep tid e side-chains w ith liquid H F to yield the N -a-acety lated A zagly111-L H R H analogs. T he final products w ere purified w ith significantly less difficulty than was o u r ex p eri ence on the A zagly10-analogs previously re p o rte d [1] , T he new p rocedure on hydrazinolysis of N -a-f-Bocp ro tec ted peptide-resins is superior to the one w here N -acetyl-peptides w ere cleaved from the resin. A lso, conversion of the C -term inal hydrazide m oiety to A zagly1" by the m ethod of D u tta and M orley [6] us ing sodium cyanate was b etter than the laborious azide coupling w ith sem icarbazide.
T he analogs in T able I have N -A c -3ZJPro' and p F -D -P h e2. V ariations w ere intro d u ced at po si tions 3, 6 and 10. [N -A c -3J P r o \ p F -D -P h e2, D -T rp 3-6, A zagly1"] com pletely inhibited ovulation in rats at 6 pg and show ed 80% inhibition at 3 ,«g/rat. In com parison, the acetylhydrazide m oiety at the Cterm inus (analog 3) show ed low er inhibitory activity; 60% at 6 ^g /rat. R eplacem ent of A zagly1" by D -A la 10 (analog 1) also caused a decreases in activi ty. A nalogs 4. 5 and 6 had D -Arg*1 m oiety, but these th ree analogs show ed no antiovulatory activity at 3 ^/g/rat, i.e. replacem ent of D -T rp'1 by D -A rg 6 was not effective in contrast to data of Coy et al. [2] on rela ted analogs.
(2-N aphthyl)-D -alanine, which is know n [3, 9] as a prom ising substituent in som e L H R H analogs, was intro d u ced into position 3 and 6, and resu lted in 25% inhibition at 25 pg. D -T rp 3 6 a p p e ared to be su p erio r to D -2-N aF'6 on com paring analogs 2 and 7. D -H istidine, which com bines basicity and arom aticity, was introduced in position 3 and 6. O n the basis of 0% inhibition at 6 ug for analog 8, D -H is3'6 was inferior to D -T rp 3,6. [10] . W hen com paring analog 9 and 10, D -A la 1" m oiety ap p e ared to be equal to G ly 10; both analogs elicited 40% inhibition at a level of 3 pg. In sertio n of A zag ly 1" m oiety to give analog 11 re sulted in loss in p otency since analog 11 caused 33% an tio v u lato ry activity at 6 pg.
R ep lacem en t of D -T rp ' in analog 10 by p C \ -D -P h e3 gave analog 13, which was inactive at 
